Contract SPE2DS21F0101
Abbott Rapid Dx North America Llc · Department Of Defense · September 2, 2021
Abbott Rapid Dx North America Llc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on September 2, 2021 for $357.00 million of work in in-vitro diagnostic substance manufacturing. Performance is in Orlando, FL. This is a task or delivery order issued under parent IDIQ SPE2DE21D0023. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 23, 2021.
Contract details
- PIID
- SPE2DS21F0101
- Parent IDIQ
- SPE2DE21D0023
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Orlando, FL
- First action
- September 2, 2021
- Latest action
- September 23, 2021
Description
8508501022!BINAXNOWTEST KIT (EA)
Modification timeline
-
September 23, 2021Mod P00002 · Change Order$357.00M
-
September 16, 2021Mod P00001 · Change Order$357.00M
-
September 2, 2021Base award$357.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2DS21F0101?
Contract SPE2DS21F0101 is a federal contract awarded to Abbott Rapid Dx North America Llc by Department Of Defense on September 2, 2021 for $357.00 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract SPE2DS21F0101?
Abbott Rapid Dx North America Llc won contract SPE2DS21F0101 from Department Of Defense.
How much is contract SPE2DS21F0101 worth?
Contract SPE2DS21F0101 has obligated $357.00 million to date.